Although no significant differences were observed, we found that treatment of Lair1+/+ mice with anti-PD-L1 monotherapy or combination therapy with NC410 resulted in reduced tumour growth compared to isotype, with 1 out of 10 mice demonstrating full clearance after combination treatment (Fig. 5A, top-centre and top-right). This evidence concerns the gene LAIR1 and neoplasm.